Aileron Therapeutics has secured the second tranche in its series D financing, meaning the overall total has now reached $42 million (pound 26 million). This payment followed the successful progression of the company's ALRN-5281 lead ...
Gilead Sciences, a biopharmaceutical company, has submitted a new drug application (NDA) to the FDA for HIV integrase inhibitor elvitegravir for the treatment-experienced patients. The company provided 96-week data from a pivotal Phase ...
One day, pharmaceutical companies might not have to test new drugs on animals or even humans. Instead, drugs could be tested with organ-on-a-chip technologies. These are not silicon chips that simulate organs or organisms, mind you; they ...
Tags: Organs, Chip, Harvard, Human Body, Silicon
Proteonomix, a developer of human cells based therapeutics, has licensed rights to use its anti-tumor technology. The technology comprises methods for isolation and propagation of the primary human cells, gene profiles obtained from the ...
Tags: Proteonomix, anti-tumor technology
Sunscreen could cause skin cancer? Study Study Suggests That Sunscreen Could Cause Skin Cancer Too much sun damages skin, but sunscreen have the same effect, suggests new scientific discoveries. Cell toxicity studies carried out at ...
Tags: Sunscreen, skin cancer, sunlight